117 related articles for article (PubMed ID: 37302026)
21. Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma.
Tawadros AIF; Khalafalla MMM
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1063-S1069. PubMed ID: 30539847
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of BAF57 expression in patients with endometrial carcinoma.
Kagami S; Kurita T; Kawagoe T; Toki N; Matsuura Y; Hachisuga T; Matsuyama A; Hashimoto H; Izumi H; Kohno K
Histol Histopathol; 2012 May; 27(5):593-9. PubMed ID: 22419023
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
24. EMX2 is downregulated in endometrial cancer and correlated with tumor progression.
Qiu H; Yan Q; Luo X; Zhang H; Bao W; Wan X
Int J Gynecol Pathol; 2013 Mar; 32(2):193-8. PubMed ID: 23370654
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
[TBL] [Abstract][Full Text] [Related]
26. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
[TBL] [Abstract][Full Text] [Related]
27. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of syndecan-1 expression in human endometrial cancer.
Hasengaowa ; Kodama J; Kusumoto T; Shinyo Y; Seki N; Hiramatsu Y
Ann Oncol; 2005 Jul; 16(7):1109-15. PubMed ID: 15851381
[TBL] [Abstract][Full Text] [Related]
29. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
30. High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study.
Gao Y; Liu Z; Gao F; Meng XY
BMC Cancer; 2010 Apr; 10():131. PubMed ID: 20374665
[TBL] [Abstract][Full Text] [Related]
31. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
[TBL] [Abstract][Full Text] [Related]
32. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
33. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients.
Nakao K; Hirakawa T; Suwa H; Kogure K; Ikeda S; Yamashita S; Minegishi T; Kishi H
Int J Gynecol Cancer; 2018 May; 28(4):675-683. PubMed ID: 29489474
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
36. A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation.
Ding F; Gao F; Zhang S; Lv X; Chen Y; Liu Q
Sci Prog; 2021; 104(1):36850421997273. PubMed ID: 33729069
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma.
Yokoyama Y; Sato S; Futagami M; Fukushi Y; Sakamoto T; Umemoto M; Saito Y
Gynecol Oncol; 2000 Jun; 77(3):413-8. PubMed ID: 10831352
[TBL] [Abstract][Full Text] [Related]
38. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
Giatromanolaki A; Koukourakis MI; Gatter KC; Harris AL; Sivridis E
J Clin Pathol; 2008 Feb; 61(2):217-20. PubMed ID: 17513511
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer.
Zhao J; Liu T; Yu G; Wang J
Tumour Biol; 2015 Feb; 36(2):1299-306. PubMed ID: 25355598
[TBL] [Abstract][Full Text] [Related]
40. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.
Alkushi A; Lim P; Coldman A; Huntsman D; Miller D; Gilks CB
Int J Gynecol Pathol; 2004 Apr; 23(2):129-37. PubMed ID: 15084841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]